Sort by
Refine Your Search
-
from multiple high-income countries, including the UK (UKHLS), Germany (SOEP), Australia (HILDA), and the US (PSID), alongside ageing studies such as SHARE, ELSA, and TILDA. Where feasible
-
developing next-generation antimicrobial peptide (AMP)-based solutions targeting vaginal fungal infections, particularly Recurrent Vulvovaginal Candidiasis (RVVC). The project combines microbiology, molecular
-
area with several hundred currently in various stages of development. Many of these are based on using recombinant Adeno-associated virus (rAAV) as a delivery vector. If even a small portion of them
Enter an email to receive alerts for algorithm-development-"Multiple"-"Prof"-"UNIS" positions